Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1075
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3195
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
Background And Aims: Data comparing the efficacy and safety of OverStitch (Apollo Endosurgery, Marlborough, Mass, USA), X-Tack (Apollo Endosurgery), and endoscopic hand suturing (EHS) for closure of GI defects after endoscopic resection are limited. We conducted a meta-analysis of the available data.
Methods: Online databases were searched for studies evaluating different closure systems for GI defects. The outcomes of interest were technical success, clinical success, and adverse events. Pooled proportions were calculated.
Results: Fifteen studies (4 for EHS, 6 for OverStitch, 4 for X-Tack, and 1 for both OverStitch and X-Tack) were included. The pooled outcomes for EHS were 98% technical success, 96% clinical success, 2% adverse events, 3% bleeding, and 1% perforation; for OverStitch were 93% technical success, 93% clinical success, 6% adverse events, 3% bleeding, and 3% perforation; and for X-Tack were 95% technical success, 94% clinical success, 3% adverse events, 2% bleeding, and 1% perforation.
Conclusions: All 3 closure methods showed comparable high technical and clinical success rates. EHS and X-Tack had lower adverse event rates than OverStitch. Future direct comparison studies are needed to corroborate our findings.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.gie.2025.03.002 | DOI Listing |